Compare two beta-blocker options for certain heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether carvedilol and metoprolol succinate work similarly in people with heart failure with reduced pumping ability. If you already need a beta-blocker, your doctor may compare which one fits better for your situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have heart failure symptoms that are at least moderate (NYHA class II or higher)
- Have reduced heart pumping function (left ventricular ejection fraction 40% or less)
- Have a clear reason to take a beta-blocker
- No medical reasons that would make carvedilol or metoprolol unsafe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two common heart medicines, bisoprolol and verapamil, improve symptoms in adults with non-obstructive hypertrophic cardiomyopathy. It may help you and your care team understand which medicine works better for symptom control and heart function.
This trial compares two beta-blocker medications, carvedilol and metoprolol succinate, to see which one works better for people with heart failure who have an implantable cardioverter defibrillator (ICD). If you are currently taking metoprolol succinate, you may be able to switch to carvedilol and help researchers find the best treatment.
This phase 3 study tests whether a specific beta blocker selection on hemodialysis can improve cardiovascular outcomes. It focuses on certain beta blockers commonly used through the VA pharmacy and compares them in a randomized way.
This trial tests whether a low dose of metoprolol (a beta-blocker) is safe and helpful for people who have both heart failure with reduced pumping ability and COPD. The goal is to see if it can improve heart function without worsening breathing problems.
This study helps older adults with heart failure gradually increase their beta-blocker dose to a level that guidelines recommend, using an approach tailored to each person.
This trial tests whether it is safe to gradually stop beta-blocker medication in older adults with heart failure with preserved ejection fraction (a type of heart failure where the heart pumps normally but is stiff). It aims to improve quality of life by reducing unnecessary medications.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.